Julin Yang
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 17
- Drug-Induced Hepatotoxicity and Protection 10
- Pharmacogenetics and Drug Metabolism 7
-
- Peroxisome Proliferator-Activated Receptors 9
- Co-authors
- Aiming Liu (30 shared papers)Frank J. Gonzalez (9 shared papers)Manyun Dai (15 shared papers)Bin Guo (4 shared papers)Danjun Song (5 shared papers)Zhen Tan (4 shared papers)Jinshun Zhao (3 shared papers)Renke Dai (4 shared papers)
- Journals
- Pharmacological Reports (3 papers)Journal of Pharmacy and Pharmacology (2 papers)Journal of Biomedical Materials Research Part A (2 papers)Toxicology Letters (2 papers)Chemico-Biological Interactions (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Julin Yang
33 papers receiving 471 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 126
- Complementary and alternative medicine 40
- Hepatology 35
- Biological Psychiatry 4
- Speech and Hearing 12
Countries citing papers authored by Julin Yang
This map shows the geographic impact of Julin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julin Yang more than expected).
Fields of papers citing papers by Julin Yang
This network shows the impact of papers produced by Julin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julin Yang. The network helps show where Julin Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Julin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 74 | |
| 2 | 2017 | 46 | |
| 3 | 2016 | 45 | |
| 4 | 2016 | 36 | |
| 5 | 2012 | 29 | |
| 6 | 2016 | 23 | |
| 7 | 2018 | 22 | |
| 8 | 2012 | 20 | |
| 9 | 2013 | 20 | |
| 10 | 2023 | 17 | |
| 11 | 2020 | 16 | |
| 12 | 2015 | 11 | |
| 13 | 2020 | 10 | |
| 14 | 2011 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2018 | 9 | |
| 17 | 2018 | 8 | |
| 18 | 2020 | 8 | |
| 19 | 2008 | 7 | |
| 20 | 2011 | 7 |
About Julin Yang
Julin Yang is a scholar working on Pharmacology, Molecular Biology, Speech and Hearing, Hepatology and Cell Biology, having authored 33 papers that have together received 478 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (10 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Pharmacogenetics and Drug Metabolism (7 papers), Bone Tissue Engineering Materials (4 papers), Liver physiology and pathology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Noise Effects and Management (2 papers) and Polymer Surface Interaction Studies (1 paper). The work is most often cited by research in Pharmacology (126 citations), Complementary and alternative medicine (40 citations), Hepatology (35 citations), Biological Psychiatry (4 citations) and Speech and Hearing (12 citations). Julin Yang has collaborated with scholars based in China and United States. Frequent co-authors include Aiming Liu, Frank J. Gonzalez, Manyun Dai, Bin Guo, Danjun Song, Zhen Tan, Jinshun Zhao, Renke Dai, Changren Zhou and Zhong‐Ze Fang. Their work appears in journals such as Pharmacological Reports, Journal of Pharmacy and Pharmacology, Journal of Biomedical Materials Research Part A, Toxicology Letters and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.